The U.S. Patent and Trademark Office issued BC3 Technologies, Inc. patent US12,263,185 for its hemostatic material and spray method of treating a bleeding wound of a human or an animal.

SEAL Hemostatic Would Spray is the first and only FDA-cleared aerosolized chitosan for rapid management of serious arterial bleeding. Marking a significant advancement in emergency medical ...

Hemostasis—the physiological process that stops bleeding—is a critical aspect of modern medical and surgical care. While the body is naturally equipped to control bleeding, certain clinical scenarios ...

Please provide your email address to receive an email when new articles are posted on . Bentracimab restored platelet function in patients on ticagrelor with major bleeding or undergoing urgent ...

This study was performed at the Shimane Medical University Hospital and the Shimane Prefectural Central Hospital, located in Izumo City (a mid-sized city in western Japan), which cover more than ...

which helps prevent bleeding episodes that plague those with hemophilia. “It’s a different pathway in the coagulation system to rebalance hemostasis,” Benson said. “Our coagulation system ...

The court heard the gash caused arterial bleeding and the wound had to be chemically cauterised before being cleaned and closed with sutures. In an impact statement read to the court by the ...

FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...

the victim was stabbed and had deep laceration suffering arterial bleeding. So he had to be taken to the hospital for the surgery,” she said. Legal Aid duty lawyer Isabelle Shoshani proposed ...